Mark Emalfarb is a big fan of fungus. “There’s a fungus among us,” he says often.

Emalfarb, who grew up working in his family’s landscape stone business, had his first success 30 years ago, importing pumice from the Soviet Union to “stonewash” blue jeans. But the industry was moving away from stones — which clogged washing machines — to enzymes that produced the same effect.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I like many will not sign up to a site offering click bait. You waste your time and mine. Drop the wall, if I like your stuff I’ll sign up.

Your daily dose of news in health and medicine

Privacy Policy